Besplatna dostava putem Box Now paketomata i Overseas kurirske službe iznad 69,99 €.

Provjerite status narudžbe

Pridružite se zajednici ljubitelja knjige iz cijelog svijeta i ostvarite mnoštvo pogodnosti. Izradite besplatni račun

Besplatna dostava Overseas kurirskom službom iznad 69.99 €

DPD kurir 3.99 € Pošta 4.99 € Overseas 4.99 € Box Now 4.49 € GLS 4.99 € DPD točka 3.49 € GLS paketomat 3.99 €

Kontakt

Kako kupovati

Pomoć

Moj račun

▸ Prazno :-(

Besplatna dostava putem Box Now paketomata i Overseas kurirske službe iznad 69,99 €.

The CD38 molecule

Name: The CD38 molecule
Brand: LAP Lambert Academic Publishing
SKU: 19185748
Price: 25.89 EUR
Availability: InStock
Author: Ahlem Mokrane
ISBN: 9786138339779

Ahlem Mokrane

Jezik

Engleski

Knjiga Meki uvez

Libristo kod: 19185748

Nakladnici LAP Lambert Academic Publishing, studeni 2017

CD38 is a transmembrane glycoprotein type II, which is expressed on normal hematopoietic cells and i... Cijeli opis

Libristo kod: 19185748

63 b

25.89 €

Vanjske zalihe Šaljemo za 8-11 dana

30 dana za povrat kupljenih proizvoda

Kupci su kupili i

Brauchen Wir Neue Offenbarungen? (Classic Reprint) Willy Veit

Meki uvez

12.43 €

Redes sociales y mercado de trabajo : elementos para una teoría del capital relacional Félix . . . [et al. ] Requena Santos

Meki uvez

12.63 €

Tourenplanungsprobleme bei der Fahrzeugdisposition Stefan Thume

Meki uvez

26.80 €

Fisioterapia Manuel García

Tvrdi uvez

22.45 €

CD38 is a transmembrane glycoprotein type II, which is expressed on normal hematopoietic cells and in non-hematopoietic tissues. Notably, CD38 is highly expressed in multiple myeloma, chronic lymphocytic leukemia, and other diseases. CD38 plays several roles, including ectoenzyme, receptor, adhesion molecule, and is involved in signal transduction. The cytotoxic mechanisms of daratumumab, which is considered a new high affinity human therapeutic mAb against a single CD38 epitope. CD38 represents a promising target for mAb-based immunotherapy, which has already and will continue to transform the treatment landscape into diseases, including multiple myeloma.